Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy by Roggeri DP, Roggeri A

Get full text

Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues by Roggeri A, Micheletto C, Roggeri DP

Get full text

Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study by Roggeri A, Micheletto C, Roggeri DP

Get full text

Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study by Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N

Get full text

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy by Tognella S, Micheletto C, Roggeri A, Polese G, Artioli D, Senna G, Caminati M, Roggeri DP

Get full text

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs by Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M

Get full text

Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study by Roggeri DP, Cozzolino M, Mazzaferro S, Brancaccio D, Paoletti E, Roggeri A, Costanzo AM, di Luzio Paparatti U, Festa V, Messa P

Get full text